Find Academic Supervisors

• Phosphoproteomics
• Mass Spectrom
• Proteomics
• +5 more

Irina Kratchmarova is an Associate Professor at the Department of Biochemistry and Molecular Biology , University of Southern Denmark , specializing in Biomedical Mass Spectrometry and Systems Biology . Her research integrates quantitative proteomics and systems biology to investigate protein secretion in muscle and adipose tissues, post-translational modifications, and their roles in metabolic and inflammatory diseases. Phosphoproteomics and signaling networks Secretome analysis in muscle and fat Protein family interactions in cancer and reproduction Stable isotope labeling and mass spectrometry Key projects include collaborations with the Ministry of Education and Research (FSS) and foundations like Novo Nordisk and Lundbeck to study dysferlinopathies and muscle/adipose crosstalk. She has presented at institutions such as Freiburg Institute for Advanced Studies .

Wei-Ling TsouView profile

Researcher

• Neurodegeneration
• Parkinson's Disease
• Spinocerebellar Ataxias
• +3 more

Dr. Wei-Ling Tsou is a Researcher in the Department of Pharmacology at Wayne State University School of Medicine, specializing in age-related neurodegeneration and proteinopathies. Her work focuses on Spinocerebellar Ataxias (SCAs) and Parkinson’s Disease (PD), using Drosophila melanogaster and cell culture systems to study protein aggregation, oxidative stress, and therapeutic interventions. Ph.D. in Neuroscience, National Yang-Ming University, Taipei, Taiwan Post-doctoral fellow and Research Associate in Pharmacology, Wayne State University Research interests include: Protein aggregation mechanisms in PD and SCAs Polyamine metabolism in neurotoxicity and neuroprotection Ubiquitin-proteasome system and protein quality control Development of Drosophila models for neurodegenerative diseases Her publications span molecular neuroscience, genetics, and environmental toxicology, with recent work exploring: Therapeutic targeting of polyamine pathways in PD (2025) Mechanistic roles of ataxin-3 domains in SCA3 toxicity (2024-2023) Protein interactions in polyglutamine diseases (2022-2011) Dr. Tsou mentors graduate students and research assistants, emphasizing experimental design and troubleshooting. She has presented her findings at national and international conferences and contributes to scientific discourse through her research on neurodegenerative disease mechanisms.

• Cancer Research
• Molecular Oncology
• Prostate Cancer
• +3 more

Daniel O'Neill is a cancer research specialist at Newcastle University, focusing on molecular mechanisms in hormone-driven malignancies. His work centers on androgen receptor (AR) and estrogen receptor (ER) signaling pathways, with significant contributions to understanding prostate and breast cancer biology through collaborations with leading researchers including Professor Craig Robson and Dr. Luke Gaughan. His research interests span molecular oncology, epigenetic regulation, and therapeutic targeting of receptor signaling. Key areas include: AR/ER co-regulator identification (Usp12, KDM4B, SETD6) Post-translational modifications in cancer progression Apoptosis induction mechanisms in therapy-resistant tumors Epigenetic control of hormone-responsive gene networks These investigations aim to develop novel interventions for aggressive carcinomas. Analysis of his 2013-2016 publications reveals consistent focus on receptor stability mechanisms. His work demonstrates how deubiquitination (Usp12), demethylation (KDM4B), and methyltransferase activity (SETD6) govern receptor turnover and transcriptional output, establishing critical links between molecular modifications and cancer cell survival. No scientific awards were documented in the source material. O'Neill operates within Newcastle University's collaborative cancer research framework without indication of independent grant leadership or student supervision in the available records. His publications suggest integration into larger research teams investigating receptor signaling pathways, with emphasis on translational molecular oncology. While no dedicated laboratory is referenced, his work aligns with Newcastle's cancer biology initiatives, particularly in prostate cancer research where he contributed to key studies on AR regulation and therapeutic targeting mechanisms.

• Prostate Cancer
• Androgen Regulation
• Alternative Splicing
• +2 more

Karen Livermore is a researcher affiliated with Newcastle University, contributing to prostate cancer research through collaborative studies on androgen regulation and molecular mechanisms in cancer cells. Current research focuses on androgen-controlled gene expression and alternative splicing patterns Investigates glycosylation processes and their role in prostate cancer cell viability Studies cancer-associated proteins like TSPAN1 and their impact on cell migration Her work intersects with fields like molecular biology, oncology, and endocrinology, particularly examining: Androgen receptor signaling pathways Alternative mRNA isoform expression Prostate cancer progression mechanisms Collaborators include Dr Jennifer Munkley, Dr Emma Scott, and Professor Craig Robson. Recent publications (2015-2019) demonstrate sustained focus on androgen-regulated processes in prostate cancer.

Sana KoubaView profile

Assistant Professor

• Calcium Signaling
• Cancer Biology
• T Cell Function
• +2 more

Sana Kouba is an Assistant Professor at the University of Geneva , affiliated with the Intracellular Signals Research Group . Her work focuses on calcium signaling mechanisms in cancer progression and immune cell regulation. University: University of Geneva Role: Assistant Professor Email: Tamara.Bollmann@unige.ch Her research explores: Calcium signaling in cancer cell survival and metastasis Ion channel regulation via lipid modifications Role of calcium transporters in tumor microenvironment adaptation Interactions between calcium signaling and stemness in drug resistance Recent publications (2024-2025) highlight her work on genomic interrogation of calcium homeostasis, S-acylation of Ca2+ transport proteins, and functional roles of ion channels like TRPC1 and Orai3 in pancreatic, prostate, and breast cancers. Earlier works (2013-2020) span molecular spectroscopy and lipidic modulators of ion channels. Scientific Awards : No awards listed in provided data. Advising & Grants : No specific students, grants, or labs mentioned in scraped content.

Jim WilsonView profile

Professor

• Human Genetics
• Population Genetics
• Genetic Epidemiology
• +5 more

Jim Wilson is Professor of Human Genetics at the University of Edinburgh, jointly affiliated with the Usher Institute and the MRC Human Genetics Unit within the College of Medicine and Veterinary Medicine. He holds a personal Chair and serves in the Deanery of Molecular, Genetic and Population Health Sciences. His educational background includes a first-class BSc in Genetics from the University of Edinburgh (1997) and a DPhil in Human Population Genetics from the University of Oxford (2002), with research training under Nobel laureate Svante Pääbo and David Goldstein. Wilson's research spans population genetics, disease genetics, and genetic epidemiology, with particular focus on: Genetic architecture of complex traits influencing diseases like heart disease and diabetes Founder effects and pathogenic variants in Scottish island populations Homozygosity and recessive genetic variants through the ROHgen consortium Genetic history of the British Isles including Norse Viking ancestry He leads the Viking Genes studies in Orkney, Shetland and the Western Isles, which combine rich phenotyping, deep genotyping, and biobanking to identify disease associations. His extensive publication portfolio (over 300 peer-reviewed articles) consistently explores genetic epidemiology methods, population-specific variant discovery, and the interface between genetic history and modern disease risk. Recent work focuses on translating genetic discoveries into clinical applications through population screening programs. Wilson has received significant recognition including: Royal Society University Research Fellowship Thomson-Reuters Highly Cited Researcher (2014-2017) Fellow of the Royal Society of Edinburgh IFTA awards for science communication programs He leads multiple funded projects including: Return of Actionable Genetics Findings to Viking Genes Participants (Wellcome Trust) Landscape of HFE gene variation across British Isles (Haemochromatosis UK) FAIR informatics tools development (Health Data Research UK) Sleep/circadian rhythm effects on brain health (multiple funders) Wilson directs the Viking Genes research program and leads an international consortium (ROHgen) involving >100 cohort studies and >1.4 million participants. His group focuses on translating population genetics findings into clinical applications, particularly regarding founder variants in Scottish populations.

Benjamin ProsserView profile

Associate Professor

• Cardiac Mechanobiology
• Cellular Biophysics
• Super-Resolution Imaging
• +4 more

Dr. Benjamin Prosser is an Associate Professor at the Department of Physiology, Perelman School of Medicine, University of Pennsylvania. He leads a multidisciplinary lab combining cellular biophysics, cardiology, and RNA biology to develop therapies for heart and brain diseases. Prosser is also a mentor in Penn's SUIP and PREP programs, hosts workshops for underrepresented STEM undergraduates, and serves on the admissions committee for the Cell Biology, Physiology and Metabolism graduate group. His research focuses on cardiac mechanobiology , particularly how microtubules regulate heart cell mechanics and signaling. Recent work has expanded into neurodevelopmental disorders following his daughter's diagnosis with STXBP1 encephalopathy, leading to antisense oligonucleotide therapy development. The lab also investigates heart failure mechanisms using human iPSC models and advanced imaging techniques. Analysis of his recent publications reveals trends in tubulin post-translational modifications , sarcomere mechanics , and neurogenetic disorders . Key collaborations include the Leducq Cytoskeletal Network , the STXBP1 Foundation , and Ionis Pharmaceuticals . Awards highlight his contributions to early career cardiology and translational research . Scientific Awards 2011 Outstanding Postdoctoral Scholar Award 2017 Linda Pechenik Montague Investigator Award 2017 AHA Early Career Investigator 2018 UM SOM Outstanding Alumnus 2021 Leducq Transatlantic Network Coordinator Prosser's lab is affiliated with the Pennsylvania Muscle Institute , Cardiovascular Institute , and professional societies including the Biophysical Society and American Heart Association . His work bridges basic science and clinical applications , emphasizing diversity initiatives in STEM training.

MIGUEL GONZALEZ BLANCOView profile

Professor

• Molecular Biology
• Genetics
• Biochemistry
• +5 more

Miguel González Blanco is a Professor at the University of Santiago de Compostela (USC), affiliated with the Faculty of Chemistry and the Department of Biochemistry and Molecular Biology . He is part of the MeMoEn research group ( Molecular mechanisms of disease ) and the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS) . His doctoral thesis, New contributions to the study of the human minisatellite MsH42, phylogeny, digestion and paradoxes (2005), was supervised by Dr. Jaime Gómez Márquez and Dr. Francisco Boan Fernández. His research focuses on DNA repair mechanisms , recombination processes , and molecular pathways underlying diseases such as cancer. Key areas include Holliday junction resolution, structure-selective endonucleases (e.g., Yen1/GEN1, Mus81), SUMOylation regulation, and RNA editing's role in cellular reprogramming. His recent work addresses the interplay between DNA repair enzymes and genomic stability in tumors, particularly pancreatic ductal adenocarcinoma. Publications highlight advancements in understanding DNA repair dynamics, retrotransposon-driven genomic rearrangements in cancer, and the functional roles of enzymes like Pif1 helicase and eIF5A. His research bridges basic molecular mechanisms with translational insights into disease pathogenesis.

Steven MansoorabadiView profile

Associate Professor

• Biochemistry
• Structural Genomics
• Cofactor Biosynthesis
• +3 more

Steven Mansoorabadi is an Associate Professor at Auburn University's Department of Chemistry and Biochemistry. His research focuses on structural and functional genomics, cofactor biosynthesis, and enzymology, with particular emphasis on tetrapyrrole metabolism. He holds a Ph.D. from the University of Wisconsin-Madison and completed postdoctoral training at the University of Texas at Austin. His laboratory integrates bioinformatics, biochemical, and biophysical approaches to study novel biosynthetic pathways. Key projects include coenzyme F430 biosynthesis in methanogenic archaea, heme d₁ maturation in Pseudomonas aeruginosa, and dinoflagellate luciferin synthesis. Recent work has explored molecular mechanisms underlying enzyme catalysis, circadian-regulated bioluminescence, and post-translational modifications in methanogenic enzymes. Publications highlight contributions to understanding radical S-adenosylmethionine enzymes, heme oxygenases, and computational modeling of protein modifications. His work bridges fundamental enzymology with practical applications in biofuel production and antibiotic development.

Frans BianchiView profile

Assistant Professor

• Membrane Proteins
• Lipid Antigens
• T Cell Activation
• +4 more

Frans Bianchi is an Assistant Professor at the University of Groningen's Faculty of Science and Engineering, affiliated with the Molecular Immunology group within the Groningen Biomolecular Sciences and Biotechnology Institute (GBB). His research focuses on membrane proteins and lipids as antigens in T cell activation and their application in vaccination strategies. Bianchi holds a PhD in Membrane Enzymology from the University of Groningen (2016) and advanced degrees in Molecular Biology and Chemistry. Research Interests: Antigen presentation mechanisms T cell receptor interactions with MHC complexes Role of lipids in immune responses Development of immunotherapeutic agents Short-chain fatty acid effects on immune cells Recent Research Themes: Recent publications highlight work on antigen processing dynamics, macrophage inflammatory responses, and diagnostic methods for cell proliferation. Notable findings include butyrate's dual inflammatory effects and novel insights into CD36 receptor function in cancer biology. His teams explore both basic immunological mechanisms and translational applications. Awards & Grants: Recipient of NWO-VENI, ZonMW Off-Road grants, and Comenius Teaching Fellowships. Collaborates on NWO Demonstrator projects for cancer cell detection technologies. Labs & Teams: Leads the Molecular Immunology group focusing on immune cell signaling and vaccine development. Collaborates with multidisciplinary teams including organic chemists and biomedical engineers.

Yvonne GarbersView profile

Professor

• Organizational Psychology
• Leadership
• Human Resource Management
• +10 more

Prof. Dr. Yvonne Garbers is a Professor of Organizational Psychology at the Institute for Communication Management , Osnabrück University of Applied Sciences, Lingen Campus. Her research focuses on organizational leadership, team dynamics, and the interplay of virtuality and diversity in workplaces. She also teaches Human Resource Management, Organizational Communication, and Applied Statistics. Education: PhD in Psychology (summa cum laude), Christian-Albrechts-Universität zu Kiel; Diplom in Psychology (grade: "Sehr gut"), CAU Kiel. Research Trends: Recent publications explore cytokine signaling in osteoarthritis, justice repair dynamics, and health impacts of workplace innovations like sit-stand desks. Her work bridges molecular biology and organizational psychology, emphasizing interdisciplinary applications. Labs & Projects: Involved in the Mittelstand-Digitalzentrum Lingen.Münster.Osnabrück and the Labor für Organisationspsychologie (Interaction & Communication section), focusing on adaptability and leadership models. Teaching: Courses include Organizational Psychology, Human Resource Management, Communication in HR, Introduction to General Psychology, and Workshops on Change and Resilience. Her contact details: Office Hours by appointment, Room KB304, Phone: 0591-80098-435, Email: y.garbers@hs-osnabrueck.de . She is married with two daughters (born 2014 and 2016).

Nicole PaulkView profile

Researcher

• Gene Therapy
• Adeno-Associated Virus (AAV) Vectors
• Rare Genetic Diseases
• +4 more

Nicole Paulk is a researcher at the University of California San Francisco (UCSF), focusing on advancing adeno-associated virus (AAV) gene therapies for rare genetic diseases and cancer. She leads the Paulk Lab, which develops technologies to improve AAV delivery, efficacy, and safety while reducing costs. Her affiliations include the UCSF Neurologic Oncology, Helen Diller Family Comprehensive Cancer Center, Glioblastoma Precision Medicine Program, and Liver Center. PhD in Viral Gene Therapy from Oregon Health & Science University (2012) Postdoctoral training in Human Gene Therapy at Stanford University (2016) BS in Medical Microbiology from Central Washington University (2006) Dr. Paulk's research centers on overcoming barriers in AAV gene therapy, including vector production, immunogenicity, and organ-specific delivery. Her work emphasizes liver diseases and glioblastoma, with recent studies exploring proteomic characterization of AAV vectors and high-dose AAV applications. Her publications highlight innovations in AAV vector engineering, proteomic analysis, and gene targeting strategies. Key grants include NIH/NIBIB U01-EB029374, NIH K01DK107607, and support from the American Society of Gene & Cell Therapy. NIH/NIBIB U01-EB029374 (2018-2023) UCSF CATALYST PROGRAM Award (2020-2021) NIH K01DK107607 (2016-2021) AMERICAN SOCIETY OF GENE & CELL THERAPY Grant (2018-2019) Dr. Paulk's lab investigates scalable solutions for AAV-based therapies, including methods for vector validation and tumor barcoding. Her interdisciplinary approach bridges virology, biotechnology, and clinical medicine to address unmet needs in genetic and oncologic conditions.

Christopher C. BenzView profile

Professor

• Oncology
• Breast Cancer Research
• Cancer Genomics
• +3 more

Christopher C. Benz is a Professor at the University of California, San Francisco, with extensive expertise in oncology and breast cancer research. His work focuses on molecular mechanisms of cancer development, biomarker discovery, and therapeutic strategies. Education: University of California, Los Angeles: B.S. in Biochemistry (1968) University of Michigan, Ann Arbor: M.D. in Medicine (1972) VGH/CCABC & UBC, Vancouver: Residency in Internal Medicine/Hematology-Oncology (1972-1978) Yale University School of Medicine: Fellowship in Oncology (1978-1979) Research Focus: Dr. Benz's interdisciplinary research integrates cancer genomics, molecular biology, and clinical oncology. He investigates breast cancer heterogeneity, tumor microenvironment interactions, metabolic vulnerabilities, and hormone receptor signaling. His TCGA contributions established foundational pan-cancer molecular classifications, while clinical studies focus on risk prediction models and long-term therapeutic outcomes. Publication Trends: Recent work demonstrates a strong emphasis on translational applications, including biomarker validation (e.g., ERpS294, IGF1R variants), therapeutic targeting of metabolic enzymes (proline dehydrogenase) and cell-cycle regulators (CDK2), and characterization of tumor-adjacent tissues. Studies frequently leverage large consortia data (TCGA, STO Trialists Group) to explore molecular subtypes and survival implications.

• Bulgarian Linguistics
• Comparative Linguistics
• Morphology
• +3 more

Serkan Cömertel is a Researcher at Trakya University's Faculty of Letters, Translation and Interpreting Department, specializing in Bulgarian linguistics. His academic foundation includes a Bachelor's degree in Translation and Interpreting (2012) and a Master's in Balkan Studies (2016), both from Trakya University. His thesis focused on the Bulgarian Conjugation System. Research Focus: His work centers on Bulgarian grammar, with emphasis on morphology, verb conjugation, and comparative Turkish-Bulgarian linguistics. Key areas include tense-aspect systems, grammatical gender, prefixation, and lexicography, reflecting deep engagement with Slavic and Balkan linguistic typology. Publications: Recent articles (2017–2022) analyze Bulgarian grammar through topics like adverbial participles, aspectual inconsistencies in dictionaries, and Turkic influences on Bulgarian verbs. His research consistently bridges theoretical linguistics and applied philology in Balkan contexts. Editorial Contributions: He has edited academic works, including the Yunus Emre Hatıra Kitabı (2021) and Pratik Bulgarca Konuşma Kılavuzu (2019), and contributed to the Türkçeden Bulgarcaya Geçen Kelimeler Sözlüğü (Dictionary of Turkisms in Bulgarian, 2016). Awards and Advisees: No scientific awards or supervised students are documented.

Jean-François CoutureView profile

Professor

• Structural Biology
• Epigenetics
• Chromatin Biology
• +3 more

Dr. Jean-François Couture is a full Professor and Chair in the Department of Biochemistry, Microbiology and Immunology at the Faculty of Medicine, University of Ottawa . His research focuses on structural biology approaches to understanding epigenetic processes, particularly in leukemia and chromatin signaling. Laval University: BSc in Microbiology Laval University: PhD in Physiology and Endocrinology University of Michigan: Postdoctoral Fellowship Research interests include: Molecular mechanisms of chromatin-interacting proteins Epigenetic regulation in acute leukemias through KMT2 family enzymes Lysine methylation in cancer progression Structural differences in plant epigenetic signaling Key trends in recent publications: Structural analysis of histone variants and nucleosome core particles Mechanistic studies of epigenetic enzyme complexes like COMPASS Structural insights into sterol-binding proteins and redox regulators Awards and recognitions: Tier 2 Canada Research Chair in Structural Biology and Epigenetics (2008-2018) Research infrastructure includes: Core facilities for X-ray crystallography and biochemical analysis Collaborations with CIHR , NSERC , and CFI